Substance P in the Gastrointestinal Tract of Non-Obese Diabetic Mice

REFERENCES

• Lock GR III. Epidemology of gastrointestinal complications of diabetes mellitus. Eur J Gastroenterol Hepatology 1995;7:711–6.
   PubMedGoogle Scholar
• Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983;98:378–84.
   PubMed Web of Science ®Google Scholar
• Allescher H, Ahmed S. Postulated physiological and pathophysiological roles on motility. In: Daniel E, editor. Neuropeptides function in gastrointestinal tract. Boston: CRC Press, Inc; 1991. p. 309–400.
   Google Scholar
• Ekblad E, Håkansson R, Sundler F. Microanatomy and chemical coding of peptide-containing neurones in the digestive tract. In: Daniel E, editor. Neuropeptides function in gastrointestinal tract. Boston: CRC Press, Inc; 1991. p. 131–80.
   Google Scholar
• Dockary GJ. Substance P and other tachykinins. In: Walsh JH, Dockary GJ, editors. Gut peptides: biochemistry and physiology. New York: Raven Press; 1994. p. 401–22.
   Google Scholar
• Donnerer J, Barthó L, Holzer P, Lermbeck F. Intestinal peristalsis associated with release of immunoreactive substance P. Neuroscience 1984;4:913–8.
   Google Scholar
• Holzer P, Maggi CA. Synergistic role of muscarinic acetylcholin and tachykinin NK-2 receptors in intestinal peristalsis. Arch Pharmacol 1994;2:194–201.
   Google Scholar
• Silkoff P, Karmeli F, Goldin E, Ewenson A, Glion C, Chorev M, et al. Effect of substance P on rat gastrointestinal transit. Dig Dis Sci 1988;33:74–7.
   PubMed Web of Science ®Google Scholar
• Lysy J, Karmeli F, Goldin E. Substance P levels in the rectal mucosa of diabetic patients with normal bowel function and constipation. Scand J Gastroenterol 1993;28:49–52.
   Google Scholar
• Belai A, Burnstock G. Changes in adrenergic and peptidergic nerves in the submucous plexus of streptozotocin-diabetic rat ileum. Gastroenterology 1990;98:1427–36.
   PubMed Web of Science ®Google Scholar
• Di Giulio AM, Tenconi B, La Croix R, Mantegazza P, Cattabeni F, Gorio A. Denervation and hyperinnervation in the nervous system of diabetic animals. I. The autonomic neuronal dystrophy of the gut. J Neurosci Res 1989;24:355–61.
   Google Scholar
• Makino S, Kunimoto K, Muraoka Y, Mitzushima Y, Katagiri K, Tochino Y. Breeding of non-obese diabetic strain of mice. Exp Anim 1980;29:1–13.
   PubMedGoogle Scholar
• Tochino Y. The NOD mouse as model of type I diabetes. CRC Crit Rev Immunol 1987;8:49–81.
   Google Scholar
• Kolb H. Mouse models of insulin dependent diabetes: low-dose streptozotocin-induced diabetes and non-obese diabetic (NOD) mice. Diabet/Metab Rev 1987;3:751–78.
   PubMed Web of Science ®Google Scholar
• Fujishima Y, Koike Y, Kaidoh T, Nishimura M, Yoshida TO. Restriction fragment length polymorphism analysis of major histocompatibility complex genes in non-obese diabetic mouse strain and its sister strains. Diabetologia 1989;32:118–25.
   Google Scholar
• Dotta F, Nayaka R, Appel MC, Bonner-Weir S, Eisenbarch CS. Anti ‘polar antigen’: a novel antibody of type I diabetic and prediabetic man and NOD mouse reacting with RIN tumour cells. Eur J Clin Invest 1989;19:A85.
   Google Scholar
• Baxter AG, Adams MA, Mandel TE. Comparsion of high- and low-diabetes incidence NOD mouse strains. Diabetes 1989;38: 1296–300.
   Google Scholar
• El-Salhy M, Zacharisson S, Spångéus A. Abnormalities of small intestinal endocrine cells in non-obese diabetic NOD mice. J Diabetes Compli. In press.
   Google Scholar
• El-Salhy M, Stenling R, Grimelius L. Peptidergic nerves and endocrine cells in the human liver. Scand J Gastroenterol 1993;28:809–15.
   PubMed Web of Science ®Google Scholar
• Weibel E, Elias H. Introduction to stereologic principles. In: Weibel E, Elias H, editors. Quantitative methods in morphology. Berlin: Springer-Verlag; 1967. p. 89–98.
   Google Scholar
• Weibel E, Stäubli RH, Hess FA. Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J Cell Biol 1969;42:68–91.
   Google Scholar
• El-Salhy M, Sandstrom O, Näsström E, Mustajbasic M, Zachrisson S. Application of computer image analysis. Histochem J 1997;29:249–55.
   Google Scholar
• El-Salhy M, Spångéus A. Antral endocrine cells in non-obese diabetic mice. Dig Dis Sci. In press.
   Google Scholar
• Spångéus A, El-Salhy M. Large intestinal endocrine cells in non-obese diabetic mice. J Diabetes Compli. In press.
   Google Scholar
• Spångéus A, El-Salhy M. Myentric plexus in the gastrointestinal tract of non-obese diabetic mice. Histol Histopathol. In press.
   Google Scholar
• Sjölund K, Sanden G, Håkanson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983;85:1120–30.
   Google Scholar
• Belai A, Lincoln J, Burnstock G. Differential effect of streptozotocin-induced diabetes on innervation of the ileum and distal colon. Gastroenterology 1991;100:1024–32.
   Google Scholar
• Milenov K, Oehme P, Bienert M, Bergmann J. Effect of substance P on mechanical and myoelectrical activities of small intestine and small intestine in conscious dog. Arch Int Pharmacodyn 1984;233:251–8.
   Google Scholar
• Holzer P. Stimulation and inhibition of gastrointestinal propulsion induced by substance P and substance K in the rat. Br J Pharmacol 1985;86:305–12.
   PubMedGoogle Scholar
• Golden E, Karmeli F, Selinger Z, Rachimilewitz D. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 1989; 34:754–57.
   PubMedGoogle Scholar
• Powel D, Cannon P, Skrabanek P, Kirrane J. The pathophysiology of substance P in man. In: Bloom SR, editor. Gut hormones. Edinburgh: Churchill Livingstone; 1978. p. 525–9.
   Google Scholar
• Domschke S, Adrian TE, Bloom SR, Lux G, Byrant MG, Domschke W. VIP, substance P and gastrin levels of gastroduodenal mucosa in celiac spure [abstract]. Gastroenterology 1982;82:1044.
   Google Scholar